Cationic liposomes for gene delivery

Expert Opinion on Drug Delivery

Volumn 2, Issue 2, 2005, Pages 237-254

  Simões, Sérgio ^a   Filipe, Ana ^c   Faneca, Henrique ^c   Mano, Miguel ^c   Penacho, Nuno ^c   Düzgünes, Nejat ^d   de Lima, Maria Pedroso ^b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Biological barriers; Clinical trials; Gene therapy; Lipoplexes; Nonviral vectors

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ALLOVECTIN 7; BETA INTERFERON; CHOLESTEROL HYDROGEN SUCCINATE; DACARBAZINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DNA; E1A PROTEIN; GANCICLOVIR; GLYCOSAMINOGLYCAN; HLA B7 ANTIGEN; INTERLEUKIN 12; LIPOPLEX; LIPOSOME; MACROGOL; PHOSPHATIDYLETHANOLAMINE; SPERMINE DERIVATIVE; THYMIDINE KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

BINDING KINETICS; BREAST CANCER; CELL INTERACTION; CELL NUCLEUS; CHEMICAL STRUCTURE; CLINICAL TRIAL; CYSTIC FIBROSIS; CYTOPLASM; DRUG FORMULATION; ENCAPSULATION; ENDOCYTOSIS; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; HYDROPHOBICITY; IN VIVO STUDY; INTERNALIZATION; MELANOMA; NONVIRAL GENE DELIVERY SYSTEM; OVARY CANCER; PHAGOCYTOSIS; REVIEW; SEMLIKI FOREST ALPHAVIRUS; STOICHIOMETRY; TRANSPORT KINETICS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CATIONS; CELL MEMBRANE; CLINICAL TRIALS; CYSTIC FIBROSIS; CYTOPLASM; DNA; FORECASTING; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; LIPOSOMES; NEOPLASMS; NUCLEAR ENVELOPE; PARTICLE SIZE; TRANSFECTION;

EID: 23744433700     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.2.237     Document Type: Review

References (138)

1. FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84(21):7413-7417.
2. PEDROSO DE LIMA MC, NEVES S, FILIPE A, DUZGUNES N, SIMOES S: Cationic liposomes for gene delivery: from biophysics to biological applications. Curr. Med. Chem. (2003) 10(14):1221-1231.
3. BEHR JP, DEMENEIX B, LOEFFLER JP, PEREZ-MUTUL J: Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. USA (1989) 86(18):6982-6986.
4. FERRARI ME, NGUYEN CM, ZELPHATI O, TSAI Y, FELGNER PL: Analytical methods for the characterization of cationic lipid-nucleic acid complexes. Hum. Gene Ther. (1998) 9(3):341-351.
5. MARSHALL J, YEW NS, EASTMAN SJ et al.: Nonviral vectors for gene therapy. In: Nonviral vectors for gene delivery. L Huang, M Hung, E Wagner (Eds), Academic Press (1999) 39-68.
6. FELGNER JH, KUMAR R, SRIDHAR CN et al.: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations, J. Biol. Chem. (1994) 269(4):2550-2561.
7. LEE ER, MARSHALL J, SIEGEL CS et al.: Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. (1996) 7(14):1701-1717.
8. FELGNER PL, TSAI YJ, SUKHU L et al.: Improved cationic lipid formulations for in vivo gene therapy. Ann. NY Acad. Sci. (1995) 772:126-139.
9. SCHEULE RK, ST GEORGE JA, BAGLEY RG et al.: Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. (1997) 8(6):689-707.
10. HUI SW, LANGNER M, ZHAO YL, ROSS P, HURLEY E, CHAN K: The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J. (1996) 71(2):590-599.
11. MOK KW, CULLIS PR: Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys. J. (1997) 73(5):2534-2545.
12. SIMOES S, SLEPUSHKIN V, GASPAR R, DE LIMA MC, DUZGUNES N: Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther. (1998) 5(7):955-964.
13. KOLTOVER I, SALDITT T, RADLER JO, SAFINYA CR: An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science (1998) 281(5373):78-81.
14. ZUIDAM NJ, BARENHOLZ Y: Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Biochim. Biophys. Acta (1998) 1368(1):115-128.
15. HARVIE P, WONG FM, BALLY MB: Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation. Biophys. J. (1998) 75(2):1040-1051.
16. SIMOES S, SLEPUSHKIN V, PIRES P et al.: Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther. (1999) 6(11):1798-1807.
17. LIU Y, MOUNKES LC, LIGGITT HD et al.: Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. (1997) 15(2):167-173.
18. WANG J, GUO X, XU Y, BARRON L, SZOKA FC Jr: Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J. Med. Chem. (1998) 41(13):2207-2215.
19. HONG K, ZHENG W, BAKER A, PAPAHADJOPOULOS D: Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. (1997) 400(2):233-237.
20. STERNBERG B, HONG K, ZHENG W, PAPAHADJOPOULOS D: Ultrastructural characterization of cationic liposome-DNA complexes showing enhanced stability in serum and high transfection activity in vivo. Biochim. Biophys. Acta (1998) 1375(1-2):23-35.
21. SMITH JG, WEDEKING T, VERNACHIO JH, WAY H, NIVEN RW: Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation. Pharm. Res. (1998) 15(9):1356-1363.
22. SONG YK, LIU F, CHU S, LIU D: Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther. (1997) 8(13):1585-1594.
23. TOMLINSON E, ROLLAND AP: Controllable gene therapy: pharmaceutics of non-viral gene delivery systems. J. Control. Rel. (1996) 39:357-372.
24. RADLER JO, KOLTOVER I, SALDITT T, SAFINYA CR: Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science (1997) 275(5301):810-814.
25. EASTMAN SJ, SIEGEL C, TOUSIGNANT J et al.: Biophysical characterization of cationic lipid: DNA complexes. Biochim. Biophys. Acta (1997) 1325(1):41-62.
26. PIRES P, SIMOES S, NIR S, GASPAR R, DUZGUNES N, PEDROSO DE LIMA MC: Interaction of cationic liposomes and their DNA complexes with monocytic leukemia cells. Biochim. Biophys. Acta (1999) 1418(1):71-84.
27. LEDLEY FD: Pharmaceutical approach to somatic gene therapy. Pharm. Res. (1996) 13(11):1595-1614.
28. KOE GS, WAY HL, QUETINGCO GM et al.: The effect of mixing on the formation of DNA/liposome complexes. Pharm. Res. (1997) 14:S57.
29. MAHATO RI, ROLLAND A, TOMLINSON E: Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm. Res. (1997) 14(7):853-859.
30. ZELPHATI O, NGUYEN C, FERRARI M, FELGNER J, TSAI Y, FELGNER PL: Stable and monodisperse lipoplex formulations for gene delivery. Gene Ther. (1998) 5(9):1272-1282.
31. PEDROSO DE LIMA MC, SIMOES S, PIRES P, FANECA H, DUZGUNES N: Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv. Drug Deliv. Rev. (2001) 47(2-3):277-294.
32. PEDROSO DE LIMA MC, FANECA H, MANO M, PENACHO N, DUZGUNES N, SIMOES S: Biophysical characterization of cationic liposome-DNA complexes and their interaction with cells. Methods Enzymol. (2003) 373:298-312.
33. TEMPLETON NS, LASIC DD, FREDERIK PM, STREY HH, ROBERTS DD, PAVLAKIS GN: Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol. (1997) 15(7):647-652.
34. DESHPANDE D, BLEZINGER P, PILLAI R, DUGUID J, FREIMARK B, ROLLAND A: Target specific optimization of cationic lipid-based systems for pulmonary gene therapy. Pharm. Res. (1998) 15(9):1340-1347.
35. SONG Y, KLIU D: Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration. Biochim. Biophys. Acta (1998) 1372(1):141-150.
36. YANG JP, HUANG L: Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. (1997) 4(9):950-960.
37. YANG JP, HUANG L: Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther. (1998) 5(3):380-387.
38. FANECA H, SIMOES S, PEDROSO DE LIMA MC: Association of albumin or protamine to lipoplexes: enhancement of transfection and resistance to serum. J. Gene Med. (2004) 6(6):681-692.
39. SIMOES S, SLEPUSHKIN V, PIRES P, GASPAR R, PEDROSO DE LIMA MC, DUZGUNES N: Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim. Biophys. Acta (2000) 1463(2):459-469.
40. MEYER O, KIRPOTIN D, HONG K et al.: Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J. Biol. Chem. (1998) 273(25):15621-15627.
41. USTER PS, ALLEN TM, DANIEL BE, MENDEZ CJ, NEWMAN MS, ZHU GZ: Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett. (1996) 386(2-3):243-246.
42. MAURER N, MORI A, PALMER L et al.: Lipid-based systems for the intracellular delivery of genetic drugs. Mol. Membr. Biol. (1999) 16(1):129-140.
43. ZHANG YP, SEKIROV L, SARAVOLAC EG et al.: Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties. Gene Ther. (1999) 6(8):1438-1447.
44. WHEELER JJ, PALMER L, OSSANLOU M et al.: Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. (1999) 6(2):271-281.
45. MISLICK KA, BALDESCHWIELER JD: Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA (1996) 93(22):12349-12354.
46. KJELLEN LLINDAHL U: Proteoglycans: structures and interactions. Ann. Rev. Biochem. (1991) 60:443-475.
47. MOUNKES LC, ZHONG W, CIPRES-PALACIN G, HEATH TD, DEBS RJ: Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. (1998) 273(40):26164-26170.
48. SAWITZKY D: Protein-glycosaminoglycan interactions: infectiological aspects. Med. Microbiol. Immunol. Berl (1996) 184(4):155-161.
49. KOPATZ I, REMY JS, BEHR JP: A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J. Gene Med. (2004) 6(7):769-776.
50. RUPONEN M, YLA-HERTTUALA S, URTTI A: Interactions of polymeric and liposomall gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim. Biophys. Acta (1999) 1415(2):331-341.
51. RUPONEN M, HONKAKOSKI P, TAMMI M, URTTI A: Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J. Gene Med. (2004) 6(4):405-414.
52. WIETHOFF CM, SMITH JG, KOE GS, MIDDAUGH CR: The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans. J. Biol. Chem. (2001) 276(35):32806-32813.
53. RUPONEN M, RONKKO S, HONKAKOSKI P, PELKONEN J, TAMMI M, URTTI A: Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J. Biol. Chem. (2001) 276(36):33875-33880.
54. WROBEL I, COLLINS D: Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta (1995) 1235(2):296-304.
55. FRIEND DS, PAPAHADJOPOULOS D, DEBS RJ: Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim. Biophys. Acta (1996) 1278(1):41-50.
56. STEGMANN T, LEGENDRE JY: Gene transfer mediated by cationic lipids: lack of a correlation between lipid mixing and transfection. Biochim. Biophys. Acta (1997) 1325(1):71-79.
57. DA CRUZ MT, SIMOES S, PIRES PP, NIR S, DE LIMA MC: Kinetic analysis of the initial steps involved in lipoplex-cell interactions: effect of various factors that influence transfection activity. Biochim. Biophys. Acta (2001) 1510(1-2):136-151.
58. CONNER SD, SCHMID SL: Regulated portals of entry into the cell. Nature (2003) 422(6927):37-44.
59. REJMAN J, OBERLE V, ZUHORN IS, HOEKSTRA D: Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. (2004) 377(Pt 1):159-169.
60. ROSS PC, HUI SW: Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. (1999) 6(4):651-659.
61. XU Y, HUI SW, FREDERIK P, SZOKA FC Jr: Physicochemical characterization and purification of cationic lipoplexes. Biophys. J. (1999) 77(1):341-353.
62. BALLY MB, HARVIE P, WONG FM, KONG S, WASAN EK, REIMER DL: Biological barriers to cellular delivery of lipid-based DNA carriers. Adv. Drug Deliv. Rev. (1999) 38(3):291-315.
63. SIMOES S, SLEPUSHKIN V, PRETZER E et al.: Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. J. Leukoc. Biol. (1999) 65(2):270-279.
64. ZUHORN IS, HOEKSTRA D: On the mechanism of cationic amphiphile-mediated transfection. To fuse or not to fuse: is that the question? J. Membr. Biol. (2002) 189(3):167-179.
65. XU Y, SZOKA FC, JR.: Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry (1996) 35(18):5616-5623.
66. NOGUCHI A, FURUNO T, KAWAURA C, NAKANISHI M: Membrane fusion plays an important role in gene transfection mediated by cationic liposomes. FEBS Lett. (1998) 433(1-2):169-173.
67. BRUNNER S, SAUER T, CAROTTA S, COTTEN M, SALTIK M, WAGNER E: Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. (2000) 7(5):401-407.
68. PAGE RL, BUTLER SP, SUBRAMANIAN A, GWAZDAUSKAS FC, JOHNSON JL, VELANDER WH: Transgenesis in mice by cytoplasmic injection of polylysine/DNA mixtures. Transgenic Res. (1995) 4(6):353-360.
69. ZABNER J, FASBENDER AJ, MONINGER T, POELLINGER KA, WELSH MJ: Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. (1995) 270(32):18997-19007.
70. CORNELIS S, VANDENBRANDEN M, RUYSSCHAERT JM, ELOUAHABI A: Role of intracellular cationic liposome-DNA complex dissociation in transfection mediated by cationic lipids. DNA Cell Biol. (2002) 21(2):91-97.
71. ARONSOHN AI, HUGHES JA: Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy. J. Drug Target. (1998) 5(3):163-169.
72. CHAN CK, JANS DA: Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. Hum. Gene Ther. (1999) 10(10):1695-1702.
73. ZANTA MA, BELGUISE-VALLADIER P, BEHR JP: Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA (1999) 96(1):91-96.
74. BRANDEN LJ, MOHAMED AJ, SMITH CI: A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. (1999) 17(8):784-787.
75. MURRAY KD, ETHERIDGE CJ, SHAH SI et al.: Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core. Gene Ther. (2001) 8:453-460.
76. TAGAWA T, MANVELL M, BROWN N et al.: Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNA. Gene Ther. (2002) 9:564-576.
77. RUDOLPH C, PLANK C, LAUSIER J, SCHILLINGER U, MULLER RH, ROSENECKER J: Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. (2003) 278:11411-11418.
78. HYNDMAN L, LEMOINE JL, HUANG L, PORTEOUS DJ, BOYD AC, NAN X: HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J. Control. Release. (2004) 99:435-444.
79. LASIC D, TEMPLETON N: Liposomes in Gene therapy. Adv. Drug Deliv. Rev. (1996) 20:221-226.
80. LEE RJ, HUANG L: Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. (1996) 271(14):8481-8487.
81. SINGHAL A, HUANG L: Gene transfer in mammalian cells using liposomes as carriers, In: Gene therapeutics: methods and applications of direct gene transfer. W JA, (Ed.), Birkhauser, Boston, MA, USA (1994) 118-142.
82. SOLODIN I, BROWN CS, BRUNO MS et al.: A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry (1995) 34(41):13537-1344.
83. GORMAN CM, AIKAWA M, FOX B et al.: Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther. (1997) 4(9):983-992.
84. CROOK K, STEVENSON BJ, DUBOUCHET M, PORTEOUS DJ: Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther. (1998) 5(1):137-143.
85. EGILMEZ NK, IWANUMA YBANKERT RB: Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. Biochem. Biophys. Res. Commun. (1996) 221(1):169-173.
86. ESCRIOU V, CIOLINA C, LACROIX F, BYK G, SCHERMAN D, WILS P: Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim. Biophys. Acta (1998) 1368(2):276-288.
87. PLANK C, MECHTLER K, SZOKA FC Jr, WAGNER E: Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. (1996) 7(12):1437-1446.
88. VITIELLO L, BOCKHOLD K, JOSHI P, BWORTON RG: Transfection of cultured myoblasts in high serum concentration with DODAC:DOPE liposomes. Gene Ther. (1998) 5(10):1306-1313.
89. BOUSSIF O, LEZOUALC'H F, ZANTA MA et al.: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA (1995) 92(16):7297-7301.
90. VITIELLO L, CHONN A, WASSERMAN JD, DUFF C, WORTON RG: Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Ther. (1996) 3(5):396-404.
91. ZHOU XH, KLIBANOV AL, HUANG L: Lipophilic polylysines mediate efficient DNA transfection in mammalian cells. Biochim. Biophys. Acta (1991) 1065(1):8-14.
92. LEWIS JG, LIN KY, KOTHAVALE A et al.: A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA (1996) 93(8):3176-3181.
93. ZELPHATI O, UYECHI LS, BARRON LG, SZOKA FC Jr: Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim. Biophys. Acta (1998) 1390(2):119-133.
94. ELIYAHU H, SERVEL N, DOMB AJ, BARENHOLZ Y: Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther. (2002) 9(13):850-858.
95. BAILEY AL, SULLIVAN SM: Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim. Biophys. Acta (2000) 1468(1-2):239-252.
96. REMY JS, KICHLER A, MORDVINOV V, SCHUBER F, BEHR JP: Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc. Natl. Acad. Sci. USA (1995) 92(5):1744-1748.
97. HUG PS, LEIGHT RG: Liposomes for the transformation of eukaryotic cells. Biochim. Biophys. Acta (1991) 1097(1):1-17.
98. OGRIS M, BRUNNER S, SCHULLER S, KIRCHEIS R, WAGNER E: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. (1999) 6(4):595-605.
99. LI S, WU SP, WHITMORE M et al.: Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am. J. Physiol. (1999) 276(5 Pt 1):L796-804.
100. GULATI M, BAJAD S, SINGH S, FERDOUS AJ, SINGH M: Development of liposomal amphotericin B formulation. J. Microencapsul. (1998) 15(2):137-151.
101. TARDI PG, BOMAN NL, CULLIS PR: Liposomal doxorubicin. J. Drug Target. (1996) 4(3):129-140.
102. GABIZON A: Tailoring liposomes for cancer drug delivery: from the bench to the clinic. Ann. Biol. Clin. (1993) 51(9):811-813.
103. OSTRO MJ, CULLIS PR: Use of liposomes as injectable-drug delivery systems. Am. J. Hosp. Pharm. (1989) 46(8):1576-1587.
104. WANG CY, HUANG L: pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc. Natl. Acad. Sci. USA (1987) 84(22):7851-7855.
105. SHANGGUAN T, CABRAL-LILLY D, PURANDARE U et al.: A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for spermine-condensed plasmid DNA. Gene Ther. (2000) 7(9):769-783.
106. FAHR A, MULLER K, NAHDE T, MULLER R, BRUSSELBACH S: A new colloidal lipidic system for gene therapy. J. Liposome Res. (2002) 12(1-2):37-44.
107. TURNER C, WEIR N, CATTERALL C, BAKER TS, JONES MN: The transfection of Jurkat T-leukemic cells by use of pH-sensitive immunoliposomes. J. Liposome Res. (2002) 12(1-2):45-50.
108. ELLISON KE, BISHOPRIC NH, WEBSTER KA et al.: Fusigenic liposome-mediated DNA transfer into cardiac myocytes. J. Mol. Cell. Cardiol. (1996) 28(7):1385-1399.
109. MURPHY FA, WARING AJ, HAYNES SM, LONGMUIR KJ: Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes. Nucleic Acids Res. (2000) 28(15):2986-2992.
110. REDDY JA, LOW PS: Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J. Control. Release. (2000) 64(1-3):27-37.
111. GUO W, GOSSELIN MA, LEE RJ: Characterization of a novel diolein-based LPDII vector for gene delivery. J. Control. Release. (2002) 83(1):121-132.
112. GOSSELIN MA, GUO W, LEE RJ: Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery. Bioconjug. Chem. (2002) 13(5):1044-1053.
113. SHI G, GUO W, STEPHENSON SM, LEE RJ: Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J. Control. Release. (2002) 80(1-3):309-319.
114. REDDY JA, DEAN D, KENNEDY MD, LOW PS: Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J. Pharm. Sci. (1999) 88(11):1112-1118.
115. MAGUIRE LA, ZHANG H, SHAMLOU PA: Preparation of small unilamellar vesicles (SUV) and biophysical characterization of their complexes with poly-l-lysine-condensed plasmid DNA. Biotechnol. Appl. Biochem. (2003) 37(Pt 1):73-81.
116. HAGSTROM JE, SEBESTYEN MG, BUDKER V et al.: Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation. Biochim. Biophys. Acta (1996) 1284(1):47-55.
117. LEE M, RENTZ J, HAN SO, BULL DA, KIM SW: Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther. (2003) 10(7):585-593.
118. + cells in ADA-deficient SCID neonates. Nat. Med. (1998) 4(7):775-780.
119. BAUM BJ, GOLDSMITH CM, KOK MR et al.: Advances in vector-mediated gene transfer. Immunol. Lett. (2003) 90(2-3):145-149.
120. RAPER SE, WILSON JM, YUDKOFF M et al.: Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency. J. Inherit. Metab. Dis. (1998) 21(Suppl. 1):119-137.
121. RAPER SE, YUDKOFF M, CHIRMULE N et al.: A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum. Gene Ther. (2002) 13(1):163-175.
122. CAVAZZANA-CALVO M, HACEIN-BEY S, DE SAINT BASILE G et al.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 288(5466):669-672.
123. HACEIN-BEY-ABINA S, LE DEIST F, CARLIER F et al.: Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. (2002) 346(16):1185-1193.
124. HACEIN-BEY-ABINA S, VON KALLE C, SCHMIDT M et al.: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 302(5644):415-419.
125. HYDE SC, GILL DR, HIGGINS CF et al.: Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature (1993) 362(6417):250-255.
126. MCLACHLAN G, HO LP, DAVIDSON-SMITH H et al.: Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP. Gene Ther. (1996) 3(12):1113-1123.
127. GRIESENBACH U, FERRARI S, GEDDES DM, ALTON EW: Gene therapy progress and prospects: cystic fibrosis. Gene Ther. (2002) 9(20):1344-1350.
128. ALTON EW, STERN M, FARLEY R et al.: Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 353(9157):947-954.
129. NOONE PG, HOHNEKER KW, ZHOU Z et al.: Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol. Ther. (2000) 1(1):105-114.
130. HYDE SC, SOUTHERN KW, GILEADI U et al.: Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. (2000) 7(13):1156-1165.
131. YOSHIDA J, MIZUNO M, FUJII M et al.: Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Hum. Gene Ther. (2004) 15(1):77-86.
132. RYUKE Y, MIZUNO M, NATSUME A et al.: Growth inhibition of subcutaneous mouse melanoma and induction of natural killer cells by liposome-mediated interferon-beta gene therapy. Melanoma Res. (2003) 13(4):349-356.
133. REN H, BOULIKAS T, LUNDSTROM K, SOLING A, WARNKE PC, RAINOV NG: Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene-a Phase I/II clinical protocol. J. Neurooncol. (2003) 64(1-2):147-154.
134. XING X, YUJIAO CHANG J, HUNG M: Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy. Adv. Drug. Deliv. Rev. (1998) 30(1-3):219-227.
135. YAN DH, CHANG LS, HUNG MC: Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products. Oncogene (1991) 6(2):343-345.
136. HORTOBAGYI GN, UENO NT, XIA W et al.: Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a Phase I clinical trial. J. Clin. Oncol. (2001) 19(14):3422-3433.
137. VOGES J, RESZKA R, GOSSMANN A et al.: Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann. Neurol. (2003) 54(4):479-487.
138. EL-ANEED A: An overview of current delivery systems in cancer gene therapy. J. Control. Release. (2004) 94(1):1-14.